Friday, November 22nd, 2024

ARA US Hospitality Trust: Notice of Distribution and Forex Details for 1H2024

Key Points for Investor Actions:

  1. Distribution Amount and Record Date:
    • A distribution of 0.747 U.S. cents per Stapled Security for the period 1 January 2024 to 30 June 2024 will be made.
    • Record Date: 19 August 2024, 5:00 p.m.
    • Payment Date: 27 September 2024.
  2. Currency Options for Distribution:
    • Investors can opt to receive the distribution in U.S. dollars or Singapore dollars.
    • For those who wish to receive U.S. dollars, they must submit a Distribution Currency Election Notice by 9 September 2024, 5:30 p.m..
    • The exchange rate for those receiving Singapore dollars is set at US$1 = S$1.294 (based on 18 September 2024).

Special Notes for Investors:

  • Tax Consideration: The capital distribution is not subject to Singapore income tax, but for those liable for tax on the sale of Stapled Securities, it will reduce their cost base for tax purposes.
  • Risk Warning: The value of Stapled Securities may rise or fall, and investors face the potential loss of capital. The securities can only be traded through SGX.

Exact Dates and Prices:

  • Record Date: 19 August 2024.
  • Payment Date: 27 September 2024.
  • Distribution per Stapled Security: 0.747 U.S. cents.
  • Forex Rate for Singapore Dollar Payments: US$1 = S$1.294.

GKE Corporation Limited: Sustainability and Financial Overview for FY2024 – Key Insights for Investors

Report Summary and Key Facts: Report Date: The sustainability report is for the financial year ended 31 May 2024 and was published in September 2024. Company Performance: GKE reported a 1.56% year-on-year increase in...

EMPHASIS OF MATTER ON THE AUDITED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024(821829_Emphasis%20of%20…).

The board of directors of Capital World Limited announced that the Independent Auditor, Moore Stephens LLP, included an “Emphasis of Matter” in respect of a material uncertainty related to going concern in the Independent...

Tianjin Pharmaceutical Da Ren Tang Q3 2024 Financial Analysis: 6% Net Profit Decline Amid TCM-Focused Growth Strategy

Financial Analysis Report: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited – Q3 2024 Business Overview Core Operations and Segments: Tianjin Pharmaceutical Da Ren Tang Group operates primarily in two segments: Traditional Chinese Medicine...